Drug Type Small molecule drug |
Synonyms N-(4-methoxyphenyl) quinoline-8-sulfonamide |
Target |
Mechanism RAMP1 antagonists(receptor activity modifying protein 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Preclinical | CN | 01 Dec 2024 | |
Rheumatoid Arthritis | Preclinical | CN | 01 Dec 2024 |